Intro
President Trump announced 100 percent tariffs on imported patented medicines and updated metal duties to boost domestic manufacturing.
WASHINGTON, DC
President Donald Trump has unveiled a bold new trade strategy, placing a 100 percent tariff on specific imported patented medicines while updating duties on metal products. This major policy shift aims to encourage companies to manufacture essential drugs within the United States rather than relying on foreign suppliers.
Under these new rules, patented drugs from countries that haven’t signed pricing or production agreements with the U.S. will face the full 100 percent tax. For now, generic medicines—which make up a huge portion of exports from nations like India—are safe from these charges, though officials hinted this could change. Large companies must comply by July 31, while smaller firms have until September 29. However, businesses that commit to building American factories can see these tariffs drop significantly, even down to zero in some cases.
The President also simplified how the government taxes items containing steel, aluminum, or copper. If a product is made of less than 15 percent metal, it won’t face extra sectoral duties. However, if it contains more than 15 percent metal, a flat 25 percent tariff will be applied to its total value. While some allies like the European Union and South Korea will enjoy lower rates, the overall goal remains clear, that is boosting the domestic industry.
This announcement falls on the first anniversary of Trump’s “Liberation Day” trade plan. While critics worry about rising costs for consumers, the administration insists these moves will secure the nation’s supply chains and bring trillions in manufacturing investments back to American soil.
